Promotion of wakefulness and energy expenditure by orexin-a in the ventrolateral preoptic area

Vista sencilla de ítem
dc.contributor.authorMavanji, Vijayakumar
dc.contributor.authorPerez-Leighton, Claudio E.
dc.contributor.authorKotz, Catherine M.
dc.contributor.authorBillington, Charles J.
dc.contributor.authorParthasarathy, Sairam
dc.contributor.authorSinton, Christopher M.
dc.contributor.authorTeske, Jennifer A.
dc.date.accessioned2023-03-21T14:26:58Z
dc.date.available2023-03-21T14:26:58Z
dc.date.issued2015-09
dc.descriptionIndexación: Scopuses
dc.description.abstractStudy Objectives: The ventrolateral preoptic area (VLPO) and the orexin/hypocretin neuronal system are key regulators of sleep onset, transitions between vigilance states, and energy homeostasis. Reciprocal projections exist between the VLPO and orexin/hypocretin neurons. Although the importance of the VLPO to sleep regulation is clear, it is unknown whether VLPO neurons are involved in energy balance. The purpose of these studies was to determine if the VLPO is a site of action for orexin-A, and which orexin receptor subtype(s) would mediate these effects of orexin-A. We hypothesized that orexin-A in the VLPO modulates behaviors (sleep and wakefulness, feeding, spontaneous physical activity [SPA]) to increase energy expenditure. Design and Measurements: Sleep, wakefulness, SPA, feeding, and energy expenditure were determined after orexin-A microinjection in the VLPO of male Sprague-Dawley rats with unilateral cannulae targeting the VLPO. We also tested whether pretreatment with a dual orexin receptor antagonist (DORA, TCS-1102) or an OX2R antagonist (JNJ-10397049) blocked the effects of orexin-A on the sleep/wake cycle or SPA, respectively. Results: Orexin-A injected into the VLPO significantly increased wakefulness, SPA, and energy expenditure (SPA-induced and total) and reduced NREM sleep and REM sleep with no effect on food intake. Pretreatment with DORA blocked the increase in wakefulness and the reduction in NREM sleep elicited by orexin-A, and the OX2R antagonist reduced SPA stimulated by orexin-A. Conclusions: These data show the ventrolateral preoptic area is a site of action for orexin-A, which may promote negative energy balance by modulating sleep/wakefulness and stimulating spontaneous physical activity and energy expenditure.es
dc.description.urihttps://academic-oup-com.recursosbiblioteca.unab.cl/sleep/article/38/9/1361/2417975#google_vignette
dc.identifier.doi10.5665/sleep.4970
dc.identifier.issn0161-8105
dc.identifier.urihttps://repositorio.unab.cl/xmlui/handle/ria/47712
dc.language.isoenes
dc.publisherAssociated Professional Sleep Societies,LLCes
dc.rights.licenseAtribución 4.0 Internacional (CC BY 4.0)
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/deed.es
dc.subjectNarcolepsyes
dc.subjectOrexinses
dc.subjectSuvorexantes
dc.titlePromotion of wakefulness and energy expenditure by orexin-a in the ventrolateral preoptic areaes
dc.typeArtículoes
Archivos
Bloque original
Mostrando 1 - 1 de 1
Miniatura
Nombre:
aasm.38.9.1361.pdf
Tamaño:
578.43 KB
Formato:
Adobe Portable Document Format
Descripción:
Sleep Volume 38, Issue 9, Pages 1361 - 13701 September 2015
Descargar
Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descripción:
Descargar
Colecciones
FM - Artículos de Revista